Ibogaine in Acute Opioid Withdrawal: An Open Label Case Series

Alper, Kenneth R., Lotsof, Howard S., Frenken, Geerte M. N., Luciano, Daniel J., Bastiaans, Jan · 2000 · Annals of the New York Academy of Sciences

AI-extracted · unverified · confirm at source

NYAS proceedings of Alper1999 case series: 33 opioid-dependent patients, 76% (25/33) complete withdrawal resolution within 24h sustained 72h. One fatality. Discusses 18-MC as potential lower-psychoactivity congener.

Dosing: 19.3 ± 6.9 mg/kg (range 6–29 mg/kg) (oral)

Sample size: 33